Rockefeller Capital Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.06K Sell
308
-262
-46% -$6.43K ﹤0.01% 4240
2025
Q4
$16.3K Sell
570
-482
-46% -$13.1K ﹤0.01% 3602
2025
Q3
$31K Buy
+1,052
New +$28.8K ﹤0.01% 3134
2023
Q1
Sell
-1,381
Closed -$118K 3450
2022
Q4
$118K Sell
1,381
-21
-1% -$1.78K ﹤0.01% 1948
2022
Q3
$100K Buy
1,402
+1,179
+529% +$105K ﹤0.01% 1992
2022
Q2
$21K Buy
223
+98
+78% +$9.99K ﹤0.01% 2729
2022
Q1
$14K Hold
125
﹤0.01% 2893
2021
Q4
$16K Sell
125
-154
-55% -$21.4K ﹤0.01% 2759
2021
Q3
$39K Hold
279
﹤0.01% 2261
2021
Q2
$35K Sell
279
-2,250
-89% -$265K ﹤0.01% 2242
2021
Q1
$323K Hold
2,529
﹤0.01% 1176
2020
Q4
$454K Buy
2,529
+2,254
+820% +$501K ﹤0.01% 944
2020
Q3
$60K Buy
275
+100
+57% +$22.3K ﹤0.01% 1449
2020
Q2
$39K Buy
175
+125
+250% +$19.6K ﹤0.01% 1475
2020
Q1
$5K Buy
+50
New +$4.04K ﹤0.01% 1965

Other funds holding QDEL

Rockefeller Capital Management's QDEL Position: Q1 2026 in Review

Rockefeller Capital Management reduced its QuidelOrtho (QDEL) stake by 46% in Q1 2026, selling an estimated $6.43K and leaving 308 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #4240.

Rockefeller Capital Management first reported a position in QDEL in Q1 2020 and has held it in 15 quarters since. The position peaked at $454K in Q4 2020. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Rockefeller Capital Management held 308 shares of QuidelOrtho worth $5.06K as of Q1 2026.
  • Rockefeller Capital Management sold 262 QuidelOrtho shares in Q1 2026, an estimated $6.43K.
  • QuidelOrtho made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4240 holding.
  • Rockefeller Capital Management first reported a position in QuidelOrtho in Q1 2020 and has held it in 15 quarters since.
  • Rockefeller Capital Management's QuidelOrtho position peaked at $454K in Q4 2020.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.